Immune response and reactogenicity of an unadjuvanted intradermally delivered human papillomavirus vaccine using a first generation Nanopatch™ in rhesus macaques: An exploratory, pre-clinical feasibility assessment

The human papillomavirus (HPV) 9-valent, recombinant vaccine (Gardasil™9) helps protect young adults (males and females) against anogenital cancers and genital warts caused by certain HPV genotypes (ref. Gardasil™9 insert). This vaccine is administered intramuscularly (IM). The aim of this study was...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:Vaccine X
Huvudupphovsmän: Meyer, Brian K., Kendall, Mark A.F., Williams, Donna M., Bett, Andrew J., Dubey, Sheri, Gentzel, Renee C., Casimiro, Danilo, Forster, Angus, Corbett, Holly, Crichton, Michael, Baker, S. Ben, Evans, Robert K., Bhambhani, Akhilesh
Materialtyp: Artigo
Språk:Inglês
Publicerad: Elsevier 2019
Ämnen:
Regular paper
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC6668242/
https://ncbi.nlm.nih.gov/pubmed/31384745
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jvacx.2019.100030
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk